Technology | September 01, 2009

Portable, High-Resolution SPECT Gets FDA Clearance

inSPira HD is a portable high resolution SPECT system.

inSPira HD is a portable high resolution SPECT system.

September 1, 20009 - The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for a new portable high-resolution single photo emission computed tomography (SPECT) system, inSPira HD, NeuroLogica Corp. announced today at the XIV World Congress of Neurological Surgery in Boston, Mass. The inSPira HD is a battery powered, high resolution, portable SPECT designed primarily for brain imaging. Its reportedly provides high quality SPECT images at a clinic, ICU, OR and emergency department. inSPira HD is said to be capable of imaging any radioisotope energies between 80 - 200 keV for clinical applications such as epilepsy, Parkinson's, stroke and Alzheimer's dementia, said the manufacturer. Traditional systems whose basic principles have been around since the 1960's continue to suffer from poor spatial and contrast resolution. This has led to the term "fuzzy" imaging with 5-10mm spatial resolution in any one axis. The inSPira HD presents an entirely new method of SPECT detection, acquisition and reconstruction, which has been designed to approach 3-mm spatial resolution. For more information:

Related Content

Videos | SPECT-CT | December 12, 2018
This is a walk around of the new Spectrum Dynamics Veriton SPECT-CT nuclear imaging system introduced at the 2018 ...
Spectrum Dynamics Sues GE for Theft, Misappropriation of Trade Secrets and Unfair Competition
News | SPECT Imaging | December 06, 2018
Single-photon emission computed tomography (SPECT) cardiac imaging company Spectrum Dynamics filed a lawsuit Dec. 6,...
A PET/CT head and neck cancer scan.

A PET/CT head and neck cancer scan.

Feature | Nuclear Imaging | November 05, 2018 | By Sabyasachi Ghosh
“Experimental validation implemented in real-life situations and not theoretical claims exaggerating small advantages
Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software
Technology | Nuclear Imaging | July 16, 2018
At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia...
Cardiac MRI being performed at the DeBakey Heart Hospital.

Cardiac MRI being performed at the DeBakey Heart Hospital.

Feature | Cardiac Imaging | May 03, 2018 | By Jeff Zagoudis
Magnetic resonance imaging (MRI) for cardiac assessment provides a radiation-free alternative to other commonly used...
The Chalk River nuclear reactor license has been renewed, but will be decommissioned by 2028.

The Chalk River nuclear isotope reactor license has been renewed, but will be decommissioned by 2028. The reactor supplies about 50 percent of the world's supply of Tc99m.

Feature | Nuclear Imaging | April 02, 2018 | Dave Fornell
April 2, 2018 – The Canadian Nuclear Safety Commission (CNSC) announced March 29 that it renewed Canadian Nuclear Lab
A Tc99m SPECT cardiac exam showing myocardial perfusion in the heart.

Technetium-99m is primarily used for the detection of cancer and to assess perfusion defects in the heart caused by heart attacks or other conditions.

Feature | Radiopharmaceuticals and Tracers | February 08, 2018 | Dave Fornell
February 8, 2018 — The U.S.
Videos | Nuclear Imaging | August 24, 2017
Prem Soman, M.D., director of nuclear cardiology at the Heart and Vascular Institute, University of Pittsburgh, and p
GE Healthcare SPECT/CT and PET/CT Systems Enhance Personalized Patient Care
News | Nuclear Imaging | June 10, 2017
GE Healthcare showcased positron emission tomography (PET) and single photon emission computed tomography/computed...
advanced visualization
News | Molecular Imaging | June 09, 2017
The Food and Drug Administration (FDA) has cleared syngo.via VB20 for Molecular Imaging (MI) from Siemens Healthineers...